Session

Infectious challenges of urology

Poster Session 06

  • Location:
    Room Milan, North Hall (Level 1)
  • Chairs:
     R. Bartoletti, Pisa (IT)
     B. Köves, Budapest (HU)
     P. Tenke, Budapest (HU)
  • Aims and objectives of this session

    This session presents the latest information for the care of your patients.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
75
Morbidity and mortality outcomes in urosepsis compared according to new sepsis definitions: A prospective multinational observational study – systemic inflammatory response syndrome protects its value

By: Tandoğdu Z.1, Koves B.2, Cai T.3, Platz A.4, Wagenlehner F.4, Bjerklund Johansen T.E.5

Institutes: 1Oslo University, Institute of Clinical Medicine, Oslo, Norway, 2South Pest Teaching Hospital, Dept. of Urology, Budapest, Hungary, 3Santa Chiara Hospital, Dept. of Urology, Trento, Italy, 4Universitätsklinikum Gießen und Marburg GmbH, Pediatric Urology and Andrology, Giessen, Germany, 5Oslo University, Dept. of Urology and Institute of Clinical Medicine, Oslo, Norway

76
Risk factors for mortality in patients with urosepsis

By: Fukunaga A., Kawakita M.

Institutes: Kobe City Medical Center General Hospital, Dept. of Urology, Kobe, Japan

78
A novel predictive tool for Asian Fournier’s gangrene: 40 cases and 15-year-experience of a tertiary center

By: Lin Y-H.1, Lu Y-C.2, Hong J-H.2, Liao C-H.1, Huang K-H.2, Huang C-Y.2, Liu S-P.2, Pu Y-S.2

Institutes: 1Cardinal Tien Hospital, Division of Urology, Dept. of Surgery, New Taipei City, Taiwan, 2National Taiwan University Hospital, Dept. of Urology, Taipei, Taiwan

79
Identification of distant subcutaneous spreading of Fournier’s gangrene by intraoperative ultrasound

By: Cantoro D.1, Galosi A.B.1, Maselli G.1, Sbrollini G.1, Fulvi P.1, Dell’Atti L.2

Institutes: 1Università Politecnica Delle Marche – Ospedali Riuniti di Ancona, Dept. of Urology, Ancona, Italy, 2Ospedale S. Anna, Dept. of Urology, Ferrara, Italy

80
Five-year prospective study evaluating healthcare-associated infections (HAIs) in a urology ward: Risk factors, microbiological characteristics and resistance patterns

By: Medina Polo J., Sopeña-Sutil R., Benítez-Sala R., Lara-Isla A., Alonso-Isa M., Gil-Moradillo J., Justo-Quintas J., Garcia-Rojo E., González-Padilla D.A., González-Díaz A., Abad-López P., Passas-Martínez J.B., Tejido-Sánchez A.

Institutes: Hospital Universitario 12 de Octubre, Dept. of Urology, Madrid, Spain

81
Quick SOFA score might be inadequate as initial sepsis screening system in UTI patients

By: Fujita S., Naito S., Ichiyanagi O., Kanno H., Yamagishi A., Yagi M., Kurota Y., Sakurai T., Nishida H., Shibasaki T., Kawazoe H., Kato T., Nagaoka A., Tsuchiya N.

Institutes: Yamagata University, School of Medicine, Dept. of Urology, Yamagata City, Japan

82
Detecting bacterial resistance in urine at the point of care via a custom tailored LAMP panel

By: Fritzenwanker M.1, Imirzalioglu C.1, Wagenlehner F.2, Chakraborty T.1, Schwengers O.3, Blom J.3

Institutes: 1Justus-Liebig-Universität, Institut Für Medizinische Mikrobiologie, Giessen, Germany, 2Justus-Liebig-Universität, Klinik Für Urologie, Kinderurologie Und Andrologie, Giessen, Germany, 3Justus-Liebig-Universität, Dept. of Bioinformatics and Systems Biology, Giessen, Germany

83
Establishment of a 3D organotypic urothelial cell culture model as infection model system for BK polyomavirus – viral lifecycle and identification of new therapeutic targets

By: Schneidewind L.1, Knerr-Rupp K.1, Feld P.1, Janssen M.2, Keiser M.3, Smola S.1

Institutes: 1University of The Saarland Medical Center, University of The Saarland, Dept. of Virology, Homburg, Germany, 2University of The Saarland Medical Center, University of The Saarland, Dept. of Urology and Paediatric Urology, Homburg, Germany, 3University Medicine Greifswald, Dept. of Pharmacology, Greifswald, Germany

84
Antimicrobial resistance patterns and risk factors for ciprofloxacin in Enterococcus faecalis isolates from expressed prostatic secretions of patients with chronic bacterial prostatitis

By: Lee G.1, Seo Y.1, Song J.2

Institutes: 1Dankook University Medical College, Dept. of Urology, Cheonan, South Korea, 2Yonsei University Wonju College of Medicine, Dept. of Urology, Wonju, South Korea

85
Withdrawn

By:

Institutes:

86
Prostatic secretion microbiota and chronic bacterial prostatitis symptoms or signs: Is there a connection?

By: Kogan M.I.1, Naboka J.2, Gudima I.2, Ibishev H.1

Institutes: 1Rostov State Medical University, Dept. of Urology, Rostov-on-Don, Russia, 2Rostov State Medical University, Dept. of Microbiology, Rostov-on-Don, Russia

87
Does micropattern (sharklet) on urinary catheter surface reduce urinary tract infections? Results from phase I randomized open label interventional trial

By: Magyar A.1, Arthanareeswaran V.K.A.1, Soós L.1, Nagy K.1, Dobák A.2, Szilágyi I.M.3, Justh N.3, Chandra A.R.1, Köves B.1, Tenke P.1

Institutes: 1Jahn Ferenc Dél-pesti Kórház, Dept. of Urology, Budapest, Hungary, 2Corden International, Dept. of Microbiology, Budapest, Hungary, 3University of Technology and Economics, BME, Budapest, Hungary

88
How to overcome gram-positive bacterial identification in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for complicated urinary tract infection-causative bacteria?

By: Shigemura K.1, Kitagawa K.2, Yamamichi F.3, Nakano Y.1, Tokimatsu I.4, Fujisawa M.1

Institutes: 1Kobe University Graduate School of Medicine, Dept. of Urology, Kobe, Japan, 2Kobe University Graduate School of Medicine, Dept. of Internal Related, Kobe, Japan, 3Hyogo Prefectural Amagasaki General Medical Center, Dept. of Urology, Amagasaki, Japan, 4Kobe University Hospital, Infection Control Team, Kobe, Japan

89
The adherence to European Association of Urology guidelines on urological infection in a tertiary referral hospital is the right way for increasing the antimicrobial stewardship among general practitioners

By: Cai T.1, Mazzoli S.2, Verze P.3, Migno S.4, Tiscione D.1, Luciani L.1, Lanzafame P.5, Eccher C.1, Malossini G.1, Bartoletti R.6, Mirone V.3, Wagenlehner F.7, Bjerklund Johansen T.8

Institutes: 1Santa Chiara Hospital, Dept. of Urology, Trento, Italy, 2Santa Maria Annunziata Hospital, Sexually Transmitted Disease Centre, Florence, Italy, 3University of Naples, Federico II, Dept. of Urology, Naples, Italy, 4Santa Chiara Hospital, Dept. of Gynaecology and Obstetrics, Trento, Italy, 5Santa Chiara Hospital, Department of Microbiology, Trento, Italy, 6University of Pisa, Dept. of Urology, Pisa, Italy, 7Universitätsklinikum Giessen und Marburg GmbH, Justus-Liebig-Universität, Klinik und Poliklinik für Urologie, Kinderurologie und Andrologie, Giessen, Germany, 8University of Oslo, Dept. of Urology, Oslo, Norway